Schuth Alexander O.
Insider CIK 1724311 · DNLI COO and Secretary
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DNLI Denali Therapeutics Inc. | S Sale | 2026-09-01 | 2026-09-03 | 2,768 | $23.44 | $64.9K | 278,995 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2026-09-01 | 2026-09-03 | 2,768 | $23.44 | $64.9K | 278,995 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2026-08-11 | 2026-08-13 | 2,857 | $25.07 | $71.6K | 281,763 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2026-08-11 | 2026-08-13 | 2,857 | $25.07 | $71.6K | 281,763 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2026-01-06 | 2026-01-08 | 17,218 | $16.50 | $284.1K | 282,828 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2026-01-03 | 2026-01-05 | 173,100 | — | $0 | 173,100 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2026-01-03 | 2026-01-05 | 57,700 | — | $0 | 300,046 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2025-08-12 | 2025-08-14 | 2,937 | $13.58 | $39.9K | 242,346 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2025-01-07 | 2025-01-08 | 2,907 | $20.81 | $60.5K | 244,308 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2025-01-06 | 2025-01-08 | 12,255 | $20.22 | $247.8K | 247,215 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2025-01-03 | 2025-01-07 | 162,540 | — | $0 | 162,540 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2025-01-03 | 2025-01-07 | 54,180 | — | $0 | 259,470 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2024-12-27 | 2024-12-31 | 6,708 | — | $0 | 46,671 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2024-12-27 | 2024-12-31 | 6,708 | $5.28 | $35.4K | 205,290 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2024-11-22 | 2024-11-26 | 20,516 | — | $0 | 124,562 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2024-11-22 | 2024-11-26 | 20,516 | $0.68 | $14.0K | 198,582 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2024-11-07 | 2024-11-12 | 15,558 | — | $0 | 53,379 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2024-11-07 | 2024-11-12 | 15,558 | $5.28 | $82.1K | 193,624 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-11-07 | 2024-11-12 | 300 | $31.29 | $9.4K | 178,066 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-11-07 | 2024-11-12 | 2,925 | $30.72 | $89.9K | 178,366 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-11-07 | 2024-11-12 | 12,333 | $29.68 | $366.0K | 181,291 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-08-21 | 2024-08-22 | 2,547 | $24.78 | $63.1K | 178,066 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-08-20 | 2024-08-22 | 2,453 | $23.79 | $58.4K | 183,966 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-08-20 | 2024-08-22 | 3,353 | $23.54 | $78.9K | 180,613 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-08-13 | 2024-08-15 | 2,272 | $22.89 | $52.0K | 186,419 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-02-14 | 2024-02-15 | 20,128 | $17.66 | $355.5K | 187,341 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-02-13 | 2024-02-15 | 2,716 | $17.29 | $47.0K | 207,469 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2024-02-08 | 2024-02-12 | 50,000 | — | $0 | 145,078 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2024-02-08 | 2024-02-12 | 50,000 | $0.68 | $34.0K | 210,185 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-01-05 | 2024-01-09 | 9,972 | $19.43 | $193.8K | 539,307 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2024-01-03 | 2024-01-05 | 161,160 | — | $0 | 161,160 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2024-01-03 | 2024-01-05 | 53,720 | — | $0 | 170,157 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-08-23 | 2023-08-25 | 2,522 | $23.17 | $58.4K | 518,989 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-08-21 | 2023-08-23 | 2,478 | $22.59 | $56.0K | 521,511 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-08-14 | 2023-08-16 | 2,772 | $23.67 | $65.6K | 518,989 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-08-10 | 2023-08-14 | 2,853 | $24.18 | $69.0K | 521,761 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-07-18 | 2023-07-19 | 9,702 | $30.01 | $291.2K | 518,989 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2023-07-17 | 2023-07-19 | 10,000 | — | $0 | 68,937 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2023-07-17 | 2023-07-19 | 10,000 | $5.28 | $52.8K | 538,691 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-07-17 | 2023-07-19 | 10,000 | $29.60 | $296.0K | 528,691 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2023-05-15 | 2023-05-17 | 10,000 | — | $0 | 78,937 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-05-15 | 2023-05-17 | 800 | $29.23 | $23.4K | 528,691 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-05-15 | 2023-05-17 | 9,200 | $28.55 | $262.7K | 529,491 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2023-05-15 | 2023-05-17 | 10,000 | $5.28 | $52.8K | 538,691 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2023-04-13 | 2023-04-14 | 4,898 | — | $0 | 88,937 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-04-13 | 2023-04-14 | 4,898 | $25.04 | $122.6K | 528,691 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2023-04-13 | 2023-04-14 | 4,898 | $5.28 | $25.9K | 533,589 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2023-04-12 | 2023-04-14 | 5,102 | — | $0 | 93,835 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2023-04-12 | 2023-04-14 | 5,102 | $5.28 | $26.9K | 533,793 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-04-12 | 2023-04-14 | 5,102 | $25.04 | $127.8K | 528,691 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2023-02-13 | 2023-02-15 | 25,000 | — | $0 | 195,078 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2023-02-13 | 2023-02-15 | 25,000 | $0.68 | $17.0K | 524,902 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-02-13 | 2023-02-15 | 3,497 | $30.09 | $105.2K | 528,691 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-02-08 | 2023-02-10 | 1,521 | $30.89 | $47.0K | 499,902 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2023-01-17 | 2023-01-19 | 10,000 | — | $0 | 98,937 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-01-17 | 2023-01-19 | 9,886 | $29.53 | $291.9K | 497,287 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-01-17 | 2023-01-19 | 114 | $29.87 | $3.4K | 497,173 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2023-01-17 | 2023-01-19 | 10,000 | $5.28 | $52.8K | 507,173 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-01-05 | 2023-01-09 | 2,636 | $28.44 | $75.0K | 497,173 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-01-04 | 2023-01-05 | 2,912 | $28.70 | $83.6K | 149,828 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-01-04 | 2023-01-09 | 2,912 | $28.70 | $83.6K | 492,309 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2023-01-03 | 2023-01-05 | 123,360 | — | $0 | 123,360 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2023-01-03 | 2023-01-05 | 41,120 | — | $0 | 157,578 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2022-10-07 | 2022-10-12 | 20,000 | — | $0 | 220,078 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2022-10-07 | 2022-10-12 | 20,000 | $0.68 | $13.6K | 487,471 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2022-08-19 | 2022-08-23 | 2,576 | $33.22 | $85.6K | 467,471 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2022-08-09 | 2022-08-11 | 22,500 | — | $0 | 121,458 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2022-02-11 | 2022-02-15 | 2,803 | $34.68 | $97.2K | 465,047 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2022-02-09 | 2022-02-11 | 1,423 | $37.10 | $52.8K | 460,564 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2022-01-05 | 2022-01-07 | 2,846 | $44.77 | $127.4K | 457,737 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 93,000 | — | $0 | 93,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2022-01-03 | 2022-01-05 | 31,000 | — | $0 | 117,454 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-12-06 | 2021-12-08 | 2,800 | $41.82 | $117.1K | 460,283 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-12-06 | 2021-12-08 | 7,200 | $42.45 | $305.6K | 453,083 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-11-04 | 2021-11-08 | 6,717 | $52.65 | $353.7K | 466,366 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-11-04 | 2021-11-08 | 3,283 | $53.23 | $174.8K | 463,083 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-10-04 | 2021-10-06 | 5,994 | $50.24 | $301.1K | 477,089 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-10-04 | 2021-10-06 | 4,006 | $51.04 | $204.5K | 473,083 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2021-09-20 | 2021-09-22 | 9,045 | — | $0 | 240,078 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2021-09-20 | 2021-09-22 | 9,045 | $0.68 | $6.2K | 95,499 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-09-07 | 2021-09-09 | 2,441 | $56.05 | $136.8K | 474,038 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-09-07 | 2021-09-09 | 5,350 | $55.67 | $297.8K | 476,479 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-09-07 | 2021-09-09 | 2,209 | $54.70 | $120.8K | 481,829 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-08-19 | 2021-08-23 | 196 | $50.10 | $9.8K | 484,038 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-08-19 | 2021-08-23 | 2,348 | $49.56 | $116.4K | 484,234 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-08-04 | 2021-08-06 | 1,564 | $51.52 | $80.6K | 490,018 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-08-04 | 2021-08-06 | 8,236 | $52.34 | $431.1K | 481,782 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-08-04 | 2021-08-06 | 200 | $52.99 | $10.6K | 481,582 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-07-06 | 2021-07-08 | 10,000 | $76.20 | $762.0K | 491,582 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-06-04 | 2021-06-08 | 4,340 | $64.82 | $281.3K | 501,582 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-06-04 | 2021-06-08 | 5,660 | $64.35 | $364.2K | 505,922 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-05-04 | 2021-05-06 | 3,557 | $55.92 | $198.9K | 512,027 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-05-04 | 2021-05-06 | 445 | $57.39 | $25.5K | 511,582 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-05-04 | 2021-05-06 | 5,998 | $55.09 | $330.4K | 515,584 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-04-05 | 2021-04-06 | 5,144 | $55.60 | $286.0K | 526,438 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-04-05 | 2021-04-06 | 4,156 | $56.47 | $234.7K | 522,282 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-04-05 | 2021-04-06 | 700 | $57.44 | $40.2K | 521,582 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-04 | 2021-03-04 | 1,878 | $61.58 | $115.6K | 531,582 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-04 | 2021-03-04 | 8,122 | $60.89 | $494.5K | 533,460 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-02-11 | 2021-02-16 | 433 | $71.41 | $30.9K | 541,582 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-02-11 | 2021-02-16 | 2,614 | $70.17 | $183.4K | 542,015 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-02-09 | 2021-02-11 | 1,262 | $74.66 | $94.2K | 537,550 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-02-09 | 2021-02-11 | 206 | $75.68 | $15.6K | 537,344 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2021-02-07 | 2021-02-11 | 4,250 | — | $0 | 8,500 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2021-02-07 | 2021-02-11 | 4,250 | — | $0 | 538,812 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-02-04 | 2021-02-05 | 1,579 | $66.65 | $105.2K | 542,983 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-02-04 | 2021-02-05 | 1,912 | $68.61 | $131.2K | 534,562 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-02-04 | 2021-02-05 | 6,509 | $67.90 | $442.0K | 536,474 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 90,000 | — | $0 | 90,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 30,000 | — | $0 | 30,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 9,709 | $71.03 | $689.6K | 591,428 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 1,226 | $84.17 | $103.2K | 544,562 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 2,817 | $81.45 | $229.4K | 555,684 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 7,996 | $82.14 | $656.8K | 547,688 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 1,400 | $65.17 | $91.2K | 613,162 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 1,100 | $66.58 | $73.2K | 612,062 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 518 | $67.78 | $35.1K | 611,544 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 1,067 | $69.07 | $73.7K | 610,477 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 3,598 | $79.78 | $287.0K | 558,501 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 7,876 | $78.43 | $617.7K | 562,099 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 1,472 | $77.64 | $114.3K | 569,975 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 980 | $76.41 | $74.9K | 571,447 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 700 | $75.61 | $52.9K | 572,427 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 5,144 | $74.01 | $380.7K | 573,127 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 4,626 | $73.09 | $338.1K | 578,271 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 8,531 | $72.22 | $616.1K | 582,897 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 1,900 | $82.96 | $157.6K | 545,788 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 9,340 | $70.10 | $654.7K | 601,137 | SEC↗ |
| DNLI Denali Therapeutics Inc. | F Tax w/h | 2020-08-21 | 2020-11-30 | 1,954 | $32.88 | $64.2K | 614,562 | SEC↗ |
| DNLI Denali Therapeutics Inc. | F Tax w/h | 2020-08-21 | 2020-08-24 | 1,954 | $32.88 | $64.2K | 614,562 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2020-08-20 | 2020-11-30 | 5,643 | — | $0 | 616,516 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2020-08-20 | 2020-08-24 | 5,643 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2020-08-20 | 2020-08-24 | 5,643 | — | $0 | 616,516 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2020-08-18 | 2020-08-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2020-03-30 | 2020-04-01 | 1,427 | $19.49 | $27.8K | 28,662 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2020-02-10 | 2020-02-12 | 29,143 | — | $0 | 29,143 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2020-02-10 | 2020-02-12 | 136,000 | — | $0 | 136,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2020-02-07 | 2020-04-01 | 4,250 | — | $0 | 12,750 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2020-02-07 | 2020-04-01 | 4,250 | — | $0 | 30,089 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2019-12-04 | 2019-12-05 | 3,121 | — | $0 | 108,937 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-12-04 | 2019-12-05 | 3,121 | $18.00 | $56.2K | 25,839 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-12-04 | 2019-12-05 | 2,656 | $18.00 | $47.8K | 580,710 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2019-12-04 | 2019-12-05 | 3,121 | $5.28 | $16.5K | 28,960 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2019-12-03 | 2019-12-05 | 711 | — | $0 | 112,058 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-12-03 | 2019-12-05 | 711 | $18.01 | $12.8K | 25,839 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-12-03 | 2019-12-05 | 1,012 | $18.01 | $18.2K | 583,366 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2019-12-03 | 2019-12-05 | 711 | $5.28 | $3.8K | 26,550 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-11-26 | 2019-11-26 | 229 | $18.02 | $4.1K | 584,378 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-11-25 | 2019-11-26 | 14,125 | $18.02 | $254.5K | 584,607 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-11-22 | 2019-11-26 | 646 | $18.00 | $11.6K | 598,732 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2019-10-23 | 2019-10-25 | 5,129 | — | $0 | 112,769 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2019-10-23 | 2019-10-25 | 5,129 | $5.28 | $27.1K | 25,839 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-09-09 | 2019-09-11 | 7,500 | $18.16 | $136.2K | 610,089 | SEC↗ |
| DNLI Denali Therapeutics Inc. | F Tax w/h | 2019-08-21 | 2019-08-22 | 1,975 | $18.60 | $36.7K | 20,710 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2019-08-20 | 2019-08-22 | 5,643 | — | $0 | 5,643 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2019-08-20 | 2019-08-22 | 5,643 | — | $0 | 22,685 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-08-07 | 2019-08-09 | 7,500 | $18.81 | $141.1K | 617,589 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-07-08 | 2019-07-10 | 7,100 | $20.25 | $143.8K | 625,489 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-07-08 | 2019-07-10 | 400 | $20.90 | $8.4K | 625,089 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-06-10 | 2019-06-12 | 7,500 | $18.77 | $140.8K | 632,589 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-05-13 | 2019-05-13 | 2,500 | $21.09 | $52.7K | 640,089 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-05-10 | 2019-05-13 | 2,500 | $22.19 | $55.5K | 642,589 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-05-09 | 2019-05-13 | 2,500 | $22.86 | $57.1K | 645,089 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-04-11 | 2019-04-11 | 2,512 | $27.73 | $69.7K | 647,589 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-04-10 | 2019-04-11 | 2,513 | $28.26 | $71.0K | 650,101 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-04-09 | 2019-04-11 | 2,475 | $28.17 | $69.7K | 652,614 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-03-13 | 2019-03-13 | 1,000 | $23.60 | $23.6K | 656,601 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-03-13 | 2019-03-13 | 1,512 | $24.33 | $36.8K | 655,089 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-03-12 | 2019-03-13 | 2,513 | $22.40 | $56.3K | 657,601 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-03-11 | 2019-03-13 | 275 | $21.80 | $6.0K | 660,114 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-03-11 | 2019-03-13 | 2,200 | $21.20 | $46.6K | 660,389 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-02-12 | 2019-02-12 | 1,700 | $20.24 | $34.4K | 662,589 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-02-12 | 2019-02-12 | 800 | $19.73 | $15.8K | 664,289 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-02-11 | 2019-02-12 | 1,266 | $19.35 | $24.5K | 665,089 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-02-11 | 2019-02-12 | 1,234 | $18.74 | $23.1K | 666,355 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-02-08 | 2019-02-12 | 2,500 | $18.11 | $45.3K | 667,589 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2019-02-07 | 2019-02-11 | 136,000 | — | $0 | 136,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2019-02-07 | 2019-02-11 | 17,000 | — | $0 | 17,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-01-11 | 2019-01-11 | 2,500 | $20.80 | $52.0K | 670,089 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-01-10 | 2019-01-11 | 2,500 | $19.99 | $50.0K | 672,589 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-01-09 | 2019-01-11 | 2,500 | $20.31 | $50.8K | 675,089 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2018-12-12 | 2018-12-12 | 2,500 | $20.80 | $52.0K | 677,589 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2018-12-11 | 2018-12-12 | 2,500 | $20.22 | $50.5K | 680,089 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2018-12-10 | 2018-12-12 | 2,500 | $20.18 | $50.5K | 682,589 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2018-10-02 | 2018-10-03 | 5,859 | — | $0 | 56,641 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2018-10-02 | 2018-10-03 | 1,184 | — | $0 | 117,898 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2018-10-02 | 2018-10-03 | 5,859 | $9.60 | $56.2K | 12,961 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2018-10-02 | 2018-10-03 | 1,184 | $5.28 | $6.3K | 7,102 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2018-08-20 | 2018-08-22 | 11,286 | — | $0 | 11,286 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2018-06-22 | 2018-06-26 | 5,918 | — | $0 | 119,082 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2018-06-22 | 2018-06-26 | 5,918 | $5.28 | $31.2K | 5,918 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2018-02-26 | 2018-02-28 | 180,000 | — | $0 | 180,000 | SEC↗ |